United Therapeutics Corporation (UTHR)

Operating return on assets (Operating ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	1,377,000	1,279,400	1,263,300	1,256,800	1,184,900	1,100,400	1,087,700	931,100	934,700	928,900	843,300	908,700	555,900	451,400	443,800	362,100	593,600	591,800	554,100	635,000
Total assets	US$ in thousands	7,364,000	7,123,100	6,723,200	6,495,200	7,167,000	7,023,600	6,681,300	6,346,000	6,044,500	5,781,600	5,543,300	5,359,800	5,169,100	5,048,900	4,844,900	4,641,000	4,615,000	4,411,200	4,219,400	4,025,900
Operating ROA		18.70%	17.96%	18.79%	19.35%	16.53%	15.67%	16.28%	14.67%	15.46%	16.07%	15.21%	16.95%	10.75%	8.94%	9.16%	7.80%	12.86%	13.42%	13.13%	15.77%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $1,377,000K ÷ $7,364,000K
= 18.70%

United Therapeutics Corporation's operating return on assets (ROA) has shown fluctuations over the quarters, ranging from a low of 7.80% in March 2021 to a high of 19.35% in March 2024. The trend indicates some volatility in the company's ability to generate earnings from its assets.

Overall, the operating ROA has been relatively strong, with most quarters showing double-digit percentages. The average operating ROA across all quarters is around 14.5%, suggesting that the company is efficient in using its assets to generate operating profits.

Investors and analysts may view this positively as it indicates that the company is effectively managing its assets to generate earnings. However, the downward trend in the latest quarters may warrant further investigation to understand the factors affecting the company's operational efficiency.